Home › Upcoming votes › AIM ImmunoTech Inc.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in AIM ImmunoTech Inc.’s proxy statement, with the board’s recommendation on each item. The company has filed 1 set of additional materials since; they can add to or change what is below, so check them before relying on it.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | Election of five directors Director election |
Board | For | 5 nominees; support 77% to 90% |
| 2 | Ratification of BDO USA, P.C. as independent auditor Auditor |
Board | For | 97% support |
| 3 | Advisory vote on named executive officer compensation Say on pay |
Board | For | 63% support |
From AIM ImmunoTech Inc.’s Form 8-K, filed December 17, 2025, for the meeting held December 16, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Nancy K. Bryan | 77% | — |
| Elect Director: William M. Mitchell | 79% | — |
| Elect Director: Ted D. Kellner | 90% | — |
| Elect Director: David I. Chemerow | 88% | — |
| Elect Director: Thomas K. Equels | 78% | — |
| 2. Ratification, by a non-binding advisory vote, of the selection of BDO USA, P.C | 97% | Approved |
| 3. Approval, by a non-binding advisory vote, of the compensation of the Company's named executive officers | 63% | Not approved |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.